How to treat Urticaria?

Éist leis an leathanach seo

Conas urticaria a chóireáil?

Is riocht craiceann é urticaria, ar a dtugtar hives go coitianta, a bhfuil itchy, welts ardaithe air a d'fhéadfadh a bheith le feiceáil ar aon chuid den chorp.

D'fhéadfadh fachtóirí éagsúla a bheith ina chúis leis, lena n-áirítear frithghníomhartha ailléirgeacha, ionfhabhtuithe, nó coinníollacha leighis bunúsacha.

Braitheann cóireáil le haghaidh urticaria ar thromchúis an choinníollacha agus ar an gcúis atá faoi bhun.

Seo roinnt roghanna cóireála coitianta:

1. Antihistamines: Cabhraíonn na cógais seo le itching agus swelling a laghdú trí éifeachtaí histamine a bhacadh, ceimiceán a scaoileann an corp le linn imoibriú ailléirgeach.

Is féidir le frith-histamínigh thar an gcuntar mar diphenhydramine (Benadryl) nó loratadine (Claritin) a bheith éifeachtach i gcásanna éadrom.

I gcásanna níos tromchúisí, d'fhéadfadh dochtúir frith-histamines níos láidre a fhorordú.

2. Corticosteroids: I gcásanna nach bhfuil frith-histamines éifeachtach, d'fhéadfaí corticosteroids mar prednisone a fhorordú chun athlasadh a laghdú agus an córas imdhíonachta a shárú.

Is gnách go dtógtar na cógais seo ó bhéal agus is féidir leo faoiseamh tapa a thabhairt.

3. Immunosuppressants: I gcásanna urticaria ainsealach nach bhfreagraíonn do chóireálacha eile, d'fhéadfaí drugaí imdhíonacha mar cyclosporine nó methotrexate a fhorordú chun an córas imdhíonachta a shárú agus athlasadh a laghdú.

4. Omalizumab: Is frithchomhlacht monoclonal instealltach é an cógais seo a spriocann agus a chuireann bac ar imdhíonaiglobulin E (IgE), próitéin a bhfuil baint aige le imoibrithe ailléirgeacha.

Úsáidtear é de ghnáth le haghaidh urticaria ainsealach nach bhfreagraíonn do chóireálacha eile.

5. Na tarraingtí a sheachaint: Is féidir le tarraingtí a dhéanann urticaria a shainaithint agus a sheachaint cabhrú le ráigí a chosc.

I measc na gcúiseanna is coitianta tá bianna áirithe, cógais, bites feithidí, agus nochtadh do teas, fuar, nó solas na gréine.

6. Compres fuar: Is féidir le compress fuar a chur i bhfeidhm ar an limistéar a bhfuil tionchar aige cuidiú le itching agus swelling a laghdú.

7. Wraps fliuch: Is féidir wraps fliuch a úsáid chun itching a mhaolú agus athlasadh a laghdú.

Cuirtear éadaí fliuch timpeall an cheantair a bhfuil tionchar aige air, agus ansin cuirtear éadaí tirim air chun taise a choinneáil.

8. Phototherapy: Is féidir le nochtadh do sholas ultraivialait cuidiú leis an gcóras imdhíonachta a shárú agus athlasadh a laghdú i gcásanna áirithe de urticaria ainsealach.

Tá sé tábhachtach dul i gcomhairle le gairmí cúraim sláinte chun diagnóis agus cóireáil cheart a dhéanamh ar urticaria.

Is féidir leo cabhrú leis an gcúis bhunúsach a chinneadh agus an plean cóireála is oiriúnaí a mholadh.

Tagairtí

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Deleanu D, Nedelea I, Petricau C, Leru P, Dumitrascu D, Muntean A: Clinical impact of omalizumab in refractory chronic urticaria: One centre experience. Exp Ther Med. 2019, 18 (6): 5078-5081.

Grundmann SA, Kiefer S, Luger TA, Brehler R: Delayed pressure urticaria - dapsone heading for first-line therapy? J Dtsch Dermatol Ges. 2011, 9 (11): 908-12.

Staumont-Sallé D, Piette F, Delaporte E: [Etiological diagnosis and treatment of chronic urticaria]. Rev Med Interne. 2003, 24 (1): 34-44.

Akashi R, Ishiguro N, Shimizu S, Kawashima M: Clinical study of the relationship between Helicobacter pylori and chronic urticaria and prurigo chronica multiformis: effectiveness of eradication therapy for Helicobacter pylori. J Dermatol. 2011, 38 (8): 761-6.

Calogiuri G, Nettis E, Mandurino-Mirizzi A, Di Leo E, Macchia L, Foti C, Vacca A, Kounis NG: Omalizumab for the Treatment of Persistent Drug Induced Urticaria Elicited by Thienopyridines: A Case Report. Antiinflamm Antiallergy Agents Med Chem. 2020, 19 (3): 335-339.

Diúltú freagrachta: leighis

Cuirtear an suíomh gréasáin seo ar fáil chun críocha oideachais agus faisnéise amháin agus ní sholáthraíonn sé comhairle leighis nó seirbhísí gairmiúla.

Níor cheart an t-eolas a chuirtear ar fáil a úsáid chun fadhb sláinte nó galar a dhiagnóisiú nó a chóireáil, agus ba cheart dóibh siúd atá ag lorg comhairle leighis phearsanta dul i gcomhairle le dochtúir ceadúnaithe.

Tabhair faoi deara le do thoil go bhfuil an líonra néarónach a ghineann freagraí ar na ceisteanna, míchruinn go háirithe nuair a bhaineann sé le hábhar uimhriúil. Mar shampla, líon na ndaoine a ndearnadh diagnóis orthu le galar ar leith.

Déan comhairle do dhochtúir nó do sholáthraí sláinte cáilithe eile i gcónaí maidir le riocht leighis. Ná déan neamhaird ar chomhairle leighis ghairmiúil ná déileáil leis mar gheall ar rud éigin a léigh tú ar an suíomh Gréasáin seo. Má cheapann tú go bhféadfadh éigeandáil leighis a bheith agat, glaoigh ar 911 nó téigh go dtí an seomra éigeandála is gaire láithreach. Ní chruthaíonn an suíomh Gréasáin seo ná a úsáid aon chaidreamh dochtúir-othar. Ní dhéanann BioMedLib ná a chuid fostaithe, ná aon ranníocóir leis an suíomh Gréasáin seo aon ionadaíochtaí, sainráite nó intuigthe, maidir leis an bhfaisnéis a sholáthraítear anseo ná a úsáid.

Diúltú freagrachta: cóipchirt

Soláthraíonn an Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (an DMCA) aisíocaíocht do úinéirí cóipchirt a chreideann go sáraíonn ábhar atá le feiceáil ar an Idirlíon a gcearta faoi dhlí cóipchirt na Stát Aontaithe.

Má chreideann tú go dea-chreidimh go sáraíonn aon ábhar nó ábhar a chuirtear ar fáil i ndáil lenár suíomh Gréasáin nó lenár seirbhísí do chóipcheart, féadfaidh tú (nó do ghníomhaire) fógra a sheoladh chugainn ag iarraidh an t-ábhar nó an t-ábhar a bhaint, nó rochtain air a bhac.

Ní mór fógraí a sheoladh i scríbhinn trí ríomhphost (féach an rannán "Contact" le haghaidh seoladh ríomhphoist).

Éilíonn an DMCA go gcuimsíonn do fhógra faoi shárú cóipchirt líomhain an fhaisnéis seo a leanas: (1) cur síos ar an saothar cóipchirt atá ina ábhar don shárú líomhain; (2) cur síos ar an ábhar líomhain atá ag sárú líomhain agus faisnéis leordhóthanach chun ligean dúinn an t-ábhar a aimsiú; (3) faisnéis teagmhála duit, lena n-áirítear do sheoladh, uimhir theileafóin agus seoladh ríomhphoist; (4) ráiteas uait go bhfuil creideamh maith agat nach bhfuil an t-ábhar ar an mbealach a bhfuil gearán á dhéanamh air údaraithe ag úinéir cóipchirt, nó a ghníomhaire, nó ag oibriú aon dlí;

(5) ráiteas uait, arna shíniú faoi phionós perjury, go bhfuil an t-eolas sa fhógra cruinn agus go bhfuil an t-údarás agat na cóipchearta a éilítear a shárú a fhorfheidhmiú;

agus (6) síntiús fisiciúil nó leictreonach úinéir an chóipchirt nó duine údaraithe chun gníomhú thar ceann úinéir an chóipchirt.

D'fhéadfadh moill a bheith ar phróiseáil do ghearán mura gcuirfidh tú an t-eolas thuas go léir san áireamh.

Cumarsáid

Seol ríomhphost dúinn le haon cheist / moladh le do thoil.

How to treat urticaria?

Urticaria, commonly known as hives, is a skin condition characterized by itchy, raised welts that can appear on any part of the body.

It can be caused by various factors, including allergic reactions, infections, or underlying medical conditions.

Treatment for urticaria depends on the severity of the condition and the underlying cause.

Here are some common treatment options:

1. Antihistamines: These medications help to reduce itching and swelling by blocking the effects of histamine, a chemical released by the body during an allergic reaction.

Over-the-counter antihistamines such as diphenhydramine (Benadryl) or loratadine (Claritin) can be effective in mild cases.

In more severe cases, a doctor may prescribe stronger antihistamines.

2. Corticosteroids: In cases where antihistamines are not effective, corticosteroids such as prednisone may be prescribed to reduce inflammation and suppress the immune system.

These medications are usually taken orally and can provide quick relief.

3. Immunosuppressants: In cases of chronic urticaria that do not respond to other treatments, immunosuppressant drugs such as cyclosporine or methotrexate may be prescribed to suppress the immune system and reduce inflammation.

4. Omalizumab: This medication is an injectable monoclonal antibody that targets and blocks immunoglobulin E (IgE), a protein involved in allergic reactions.

It is typically used for chronic urticaria that does not respond to other treatments.

5. Avoid triggers: Identifying and avoiding triggers that cause urticaria can help prevent outbreaks.

Common triggers include certain foods, medications, insect bites, and exposure to heat, cold, or sunlight.

6. Cold compress: Applying a cold compress to the affected area can help reduce itching and swelling.

7. Wet wraps: Wet wraps can be used to soothe itching and reduce inflammation.

A damp cloth is wrapped around the affected area, and then a dry cloth is placed over it to retain moisture.

8. Phototherapy: Exposure to ultraviolet light can help suppress the immune system and reduce inflammation in some cases of chronic urticaria.

It is important to consult a healthcare professional for proper diagnosis and treatment of urticaria.

They can help determine the underlying cause and recommend the most appropriate treatment plan.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.

Timpeall

Úsáideann BioMedLib ríomhairí uathoibrithe (algorithms foghlama meaisín) chun péirí ceisteanna agus freagraí a ghiniúint.

Tosaímid le 35 milliún foilseachán bithleighis de PubMed/Medline. Chomh maith le leathanaigh ghréasáin de RefinedWeb.

Féach "Tuairiscí" freisin "Disclaimer".